Publications by authors named "Patrizio Vitulo"

Claim this Profile
A
An update on SARS-CoV-2 prevention strategy in solid organ transplant recipients: an expert opinion.
Paolo Antonio Grossi, Patrizia Burra, Emanuele Cozzi, Loreto Gesualdo, Giuseppe Grandaliano, Patrizio Vitulo

Transplant Rev (Orlando)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TAPSE/sPAP Ratio to Improve Risk Assessment in Pulmonary Arterial Hypertension.
Roberto Badagliacca, Khodr Tello, Michele D'Alto, Stefano Ghio, Paola Argiento, Patrizio Vitulo

Circ Heart Fail· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Survey on pulmonary arterial hypertension: a picture of the Italian reality].
Giovanna Manzi, Roberto Badagliacca, Michele D'Alto, Stefano Ghio, Alessandra Manes, Patrizio Vitulo

G Ital Cardiol (Rome)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ASPYRE-1 study: An Italian multicenter prospective study on pulmonary hypertension modality of death and validation of REVEAL risk score.
Silvia Papa, Michele D'Alto, Laura Scelsi, Mauro Acquaro, Francesca Adamo, Patrizio Vitulo

Vascul Pharmacol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating biomarkers in patients with progressive fibrosing interstitial lung disease treated with nintedanib: a pilot study.
Vitale Miceli, Adriana Callari, Elisa Calzolari, Salvatore Castelbuono, Carcione Claudia, Patrizio Vitulo

Sci Rep· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serologic screening and molecular surveillance of Kaposi sarcoma herpesvirus/human herpesvirus-8 infections for early recognition and effective treatment of Kaposi sarcoma herpesvirus-associated inflammatory cytokine syndrome in solid organ transplant recipients.
Alessandra Mularoni, Andrea Cona, Matteo Bulati, Rosalia Busà, Monica Miele, Patrizio Vitulo

Am J Transplant· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world insights into safety, tolerability, and predictive factors of adverse drug reactions in treating idiopathic pulmonary fibrosis with pirfenidone and nintedanib.
Alessio Provenzani, Daniele Leonardi Vinci, Miriam Alaimo, Salvatore Di Maria, Fabio Tuzzolino, Patrizio Vitulo

Ther Adv Drug Saf· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gaps in evidence in the treatment of prevalent patients with pulmonary arterial hypertension at intermediate risk: An expert consensus.
Giovanna Manzi, Raymond L Benza, Paola Argiento, Gavino Casu, Marco Corda, Patrizio Vitulo

Vascul Pharmacol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Right ventricular phenotyping in incident patients with idiopathic pulmonary arterial hypertension.
Stefano Ghio, Roberto Badagliacca, Michele D'Alto, Laura Scelsi, Paola Argiento, Patrizio Vitulo

J Heart Lung Transplant· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tixagevimab/Cilgavimab as SARS-CoV-2 Pre-Exposure Prophylaxis in Lung Transplant Recipients during the Omicron Wave: A Real-World Monocentric Experience.
Andrea Cona, Alessandro Tavelli, Stefano Agrenzano, Neha Hafeez, Giovanni Scianna, Patrizio Vitulo

Microorganisms· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[ANMCO/SIC Consensus statement on pulmonary arterial hypertension].
Marco Vatrano, Giovanna Manzi, Claudio Picariello, Michele D'Alto, Iolanda Enea, Patrizio Vitulo

G Ital Cardiol (Rome)· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Future Perspectives of Pulmonary Arterial Hypertension: A Review of Novel Pipeline Treatments and Indications.
Maria Eugenia Novara, Enrica Di Martino, Brandon Stephens, Mary Nayrouz, Patrizio Vitulo

Drugs R D· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathogenesis, clinical features, and phenotypes of pulmonary hypertension associated with interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative - Group 3 Pulmonary Hypertension.
Lucilla Piccari, Brian Allwood, Katerina Antoniou, Jonathan H Chung, Paul M Hassoun, Patrizio Vitulo

Pulm Circ· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The paradox of pulmonary arterial hypertension in Italy in the COVID-19 era: is risk of disease progression around the corner?
Roberto Badagliacca, Silvia Papa, Michele D'Alto, Stefano Ghio, Piergiuseppe Agostoni, Patrizio Vitulo

Eur Respir J· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune Response after the Fourth Dose of SARS-CoV-2 mRNA Vaccine Compared to Natural Infection in Three Doses' Vaccinated Solid Organ Transplant Recipients.
Rosalia Busà, Giovanna Russelli, Monica Miele, Maria Concetta Sorrentino, Mariangela Di Bella, Patrizio Vitulo

Viruses· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relevance of comorbidities on initial combination therapy in pulmonary arterial hypertension.
Roberto Badagliacca, Michele D'Alto, Stefano Ghio, Paola Argiento, Natale Daniele Brunetti, Patrizio Vitulo

ERJ Open Res· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pulmonary hypertension in interstitial lung disease: Clinical trial design and endpoints: A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative-Group 3 Pulmonary Hypertension.
Steven D Nathan, Peter Fernandes, Mitchell Psotka, Patrizio Vitulo, Lucilla Piccari

Pulm Circ· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Effect of Borderline Pulmonary Hypertension on Survival in Chronic Lung Disease.
Lucilla Piccari, Stephen John Wort, Federica Meloni, Monica Rizzo, Laura C Price, Patrizio Vitulo

Respiration· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of the Specific Immune Response after the Third Dose of mRNA COVID-19 Vaccines in Organ Transplant Recipients: Possible Spike-S1 Reactive IgA Signature in Protection from SARS-CoV-2 Infection.
Monica Miele, Rosalia Busà, Giovanna Russelli, Maria Concetta Sorrentino, Mariangela Di Bella, Patrizio Vitulo

Microorganisms· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical significance of pulmonary hypertension in interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute's innovative drug development initiative-Group 3 pulmonary hypertension.
Sylvia M Nikkho, Manuel J Richter, Eric Shen, Steven H Abman, Katerina Antoniou, Patrizio Vitulo

Pulm Circ· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Cigarette smoke alters cell cycle and induces inflammation in lung fibroblasts" [Life Sci. 126 (2015) 10-18].
Claudia D'Anna, Diego Cigna, Giorgia Costanzo, Maria Ferraro, Liboria Siena, Patrizio Vitulo

Life Sci· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cigarette smoke upregulates Notch-1 signaling pathway and promotes lung adenocarcinoma progression.
Giuseppina Chiappara, Serena Di Vincenzo, Claudia Sangiorgi, Caterina Di Sano, Claudia D'Anna, Patrizio Vitulo

Toxicol Lett· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression/Activation of PAR-1 in Airway Epithelial Cells of COPD Patients: Ex Vivo/In Vitro Study.
Angela Marina Montalbano, Giuseppina Chiappara, Giusy Daniela Albano, Maria Ferraro, Caterina Di Sano, Patrizio Vitulo

Int J Mol Sci· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impaired anti-SARS-CoV-2 humoral and cellular immune response induced by Pfizer-BioNTech BNT162b2 mRNA vaccine in solid organ transplanted patients.
Monica Miele, Rosalia Busà, Giovanna Russelli, Maria Concetta Sorrentino, Mariangela Di Bella, Patrizio Vitulo

Am J Transplant· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pulmonary vasodilator treatment in pulmonary hypertension due to left heart or lung disease: time for a high-definition picture?
Lucilla Piccari, Roberto J Bernardo, Diego Rodríguez-Chiaradía, Patrizio Vitulo, S John Wort

Pulm Circ· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis